Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
28.41
+0.05 (0.18%)
At close: Jun 27, 2025, 4:00 PM
28.60
+0.19 (0.67%)
After-hours: Jun 27, 2025, 7:57 PM EDT
Sanara MedTech Market Cap
Sanara MedTech has a market cap or net worth of $252.50 million as of June 27, 2025. Its market cap has decreased by -5.54% in one year.
Market Cap
252.50M
Enterprise Value
276.54M
1-Year Change
-5.54%
Ranking
Category
Stock Price
$28.41
Market Cap Chart
Since December 1, 1998, Sanara MedTech's market cap has increased from $5.50M to $252.50M, an increase of 4,490.98%. That is a compound annual growth rate of 15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 252.50M | -12.99% |
| Dec 31, 2024 | 290.20M | -17.30% |
| Dec 29, 2023 | 350.90M | -7.12% |
| Dec 30, 2022 | 377.80M | 67.54% |
| Dec 31, 2021 | 225.50M | -28.21% |
| Dec 31, 2020 | 314.10M | 446.26% |
| Dec 31, 2019 | 57.50M | 687.67% |
| Dec 31, 2018 | 7.30M | 8.96% |
| Dec 29, 2017 | 6.70M | 52.27% |
| Dec 30, 2016 | 4.40M | -54.64% |
| Dec 31, 2015 | 9.70M | 83.02% |
| Dec 31, 2014 | 5.30M | -43.62% |
| Dec 31, 2013 | 9.40M | 261.54% |
| Dec 31, 2012 | 2.60M | -88.79% |
| Dec 30, 2011 | 23.20M | 53.64% |
| Dec 31, 2010 | 15.10M | -79.17% |
| Dec 31, 2009 | 72.50M | -16.38% |
| Dec 31, 2008 | 86.70M | 431.90% |
| Dec 31, 2007 | 16.30M | 1,937.50% |
| Dec 29, 2006 | 800.00K | -66.67% |
| Dec 30, 2005 | 2.40M | -86.67% |
| Dec 31, 2004 | 18.00M | 8,900.00% |
| Dec 31, 2003 | 200.00K | - |
| Dec 31, 2002 | - | -100.00% |
| Dec 31, 2001 | 3.70M | -64.42% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.87B |
| Johnson & Johnson | 365.58B |
| AbbVie | 330.00B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 275.68B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.25B |
| AstraZeneca | 215.99B |